Study for theraputic effects of soy been peptides on rheumatoid arthritis-dose response study.

Study for theraputic effects of soy been peptides on rheumatoid arthritis-dose response study. - Dose response study for soy been peptide in rheumatoid arthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021635

Enrollment

Registered

2016-03-27

Start date

2014-09-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

Patients with rheumatoid arthritis were orally treated with soy been peptide (4g/day) for 8 weeks. Patients with rheumatoid arthritis were orally treated with soy been peptide (8g/day) for 8 weeks. Pa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Out patients with rheumatoid arthritis.

Exclusion criteria

Exclusion criteria: Patients with malignant tumor, or other severe diseases. Hospitalized patients.

Design outcomes

Primary

Measure	Time frame
Inhibitory effects of soy been peptide on number of tender joints, sowollen joints, and anti-pain effect.	—

Secondary

Measure	Time frame
Inbitory effects of soy been peptide on inflammation.	—

Countries

Japan

Contacts

Public ContactKazuo Yudo

St. Marianna University School of Medicine Institute of Medical Science

yudo@marianna-u.ac.jp0449778111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026